Director and 10% Owner Kosasa Thomas Invests $1M in OneMedNet at $0.69/Share
ONMD sits 50% above its 52-week low of $0.44.
Summary
OneMedNet director and 10% owner Kosasa Thomas purchased $1 million in common stock at $0.69 per share, reinforcing insider confidence as the company navigates a going concern warning and recent dilutive financing.
Key Events · Ownership and Investor Activity · ONMD
-
$1M Insider Purchase by Director/10% Owner
Kosasa Thomas acquired 1,449,275 shares at $0.69 per share for a total of $1,000,000 on July 30, 2026, increasing his direct holdings to 18,538,150 shares.
-
Significant Commitment Amid Financial Distress
The purchase represents 2.8% of OneMedNet's market cap and comes after a Q1 2026 10-Q that disclosed a going concern warning, a 30% revenue decline, and a Nasdaq delisting threat.
-
Insider Accumulation Trend Continues
This is the third open-market purchase by insiders in the past 90 days, totaling over $580,000 in net buying, signaling collective confidence in the company's outlook.
-
Priced at 10-Day VWAP
The shares were valued at the volume-weighted average price over the 10 trading days prior to the purchase, reflecting a market-based entry point rather than a discounted private placement.
Analysis · ONMD · Industrial Applications And Services
Director and 10% owner Kosasa Thomas bought $1 million worth of OneMedNet stock at $0.69 per share, a significant vote of confidence amid the company's going concern warning and recent dilutive financing. The purchase represents 2.8% of the company's market cap and adds to a pattern of insider accumulation, with three insiders buying over $580,000 in the past 90 days. This real-money commitment from a board member and major shareholder suggests belief in the company's turnaround, despite the financial distress signaled in the Q1 2026 10-Q.
At the time of this filing, ONMD was trading at $0.66 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $35.6M. The 52-week trading range was $0.44 to $4.22. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.